Allstate Corporation’s Xylem XYL Stock Holding History

Allstate Corporation’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$524K	Sell	4,431 -22,124	-83%	-$2.55M	0.01%	1009
2026 Q1	$3.17M	Buy	26,555 +8,778	+49%	+$1.15M	0.03%	352
2025 Q4	$2.42M	Buy	17,777 +8,988	+102%	+$1.29M	0.03%	324
2025 Q3	$1.3M	Buy	+8,789	New	+$1.22M	0.03%	309
2025 Q2	–	Sell	-5,831	Closed	-$697K	–	573
2025 Q1	$697K	Sell	5,831 -1,378	-19%	-$171K	0.02%	431
2024 Q4	$836K	Buy	+7,209	New	+$911K	0.02%	357
2023 Q1	–	Sell	-7,440	Closed	-$823K	–	562
2022 Q4	$823K	Hold	7,440	–	–	0.03%	391
2022 Q3	$650K	Sell	7,440 -5,062	-40%	-$460K	0.02%	438
2022 Q2	$977K	Sell	12,502 -3,158	-20%	-$261K	0.03%	349
2022 Q1	$1.33M	Buy	+15,660	New	+$1.5M	0.04%	338

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Allstate Corporation's XYL Position: Q2 2026 in Review

Allstate Corporation reduced its Xylem (XYL) stake by 83% in Q2 2026, selling an estimated $2.55M and leaving 4,431 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #1009.

Allstate Corporation first reported a position in XYL in Q1 2022 and has held it in 10 quarters since. The position peaked at $3.17M in Q1 2026. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Allstate Corporation held 4,431 shares of Xylem worth $524K as of Q2 2026.
Allstate Corporation sold 22,124 Xylem shares in Q2 2026, an estimated $2.55M.
Xylem made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #1009 holding.
Allstate Corporation first reported a position in Xylem in Q1 2022 and has held it in 10 quarters since.
Allstate Corporation's Xylem position peaked at $3.17M in Q1 2026.
1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.